In particular, GAS5 has been identified as a CDKN1-related competing endogenous RNA (ceRNA), with its upregulation driving HCC progression through the GAS5/miR-25-3p/SOX11 network15. The gene discussed is GAS5; the disease is hepatocellular carcinoma.